Vantage Financial Partners (Wisconsin)’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,800
Closed -$223K 199
2024
Q2
$223K Buy
1,800
+157
+10% +$20.2K 0.06% 133
2024
Q1
$217K Buy
+1,643
New +$203K 0.06% 132

Other funds holding MRK

Vantage Financial Partners (Wisconsin)'s MRK Position: Q3 2024 in Review

Vantage Financial Partners (Wisconsin) sold out of Merck (MRK) in Q3 2024, closing a stake of 1,800 shares — an estimated $223K sold.

Vantage Financial Partners (Wisconsin) first reported a position in MRK in Q1 2024 and held it in 2 quarters. The position peaked at $223K in Q2 2024. 3,489 funds tracked by Wall St. Rank hold MRK as of Q3 2024.

  • Vantage Financial Partners (Wisconsin) reported no remaining Merck position as of Q3 2024 after selling out during the quarter.
  • Vantage Financial Partners (Wisconsin) sold 1,800 Merck shares in Q3 2024, an estimated $223K.
  • Vantage Financial Partners (Wisconsin) first reported a position in Merck in Q1 2024 and held it in 2 quarters.
  • Vantage Financial Partners (Wisconsin)'s Merck position peaked at $223K in Q2 2024.
  • 3,489 funds tracked by Wall St. Rank held Merck as of Q3 2024.

Based on Vantage Financial Partners (Wisconsin)'s 13F filing for Q3 2024, filed 8 Nov 2024.